Subsequently, many other cancer cell lines were found to be inhibited in vivo by these antibodies and other anti-VEGFA treatments, including small-molecule inhibitors of VEGFR signaling, antisense oligonucleotides and antibodies to VEGFR-2 [34]. This evidence concerns the gene VEGFA and cancer.